Bionano Genomics, Inc.
BNGO
$4.00
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 54.15% | 60.69% | 58.31% | 15.36% | -13.48% |
| Total Depreciation and Amortization | -32.85% | 54.52% | -9.23% | -5.65% | 29.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.72% | -70.48% | -166.77% | -205.63% | 125.22% |
| Change in Net Operating Assets | 136.23% | 11.04% | 30.45% | 259.30% | -2.83% |
| Cash from Operations | 78.16% | 49.38% | 42.83% | 13.21% | 13.73% |
| Capital Expenditure | 100.00% | 100.00% | 84.93% | 92.78% | 48.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 105.49% | -116.04% | -4.28% | 181.93% | -223.00% |
| Cash from Investing | 105.41% | -116.08% | -3.20% | 187.91% | -576.94% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 77.65% | -25,025.00% | -202,833.33% | -366,670.00% | -90,030.00% |
| Issuance of Common Stock | -40.52% | -21.76% | -33.68% | 1.27% | 7,144.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.07% | -232.10% | -1,605.69% | -1.58% | -- |
| Cash from Financing | -94.32% | -52.17% | -111.06% | -245.46% | 46,806.85% |
| Foreign Exchange rate Adjustments | -108.33% | 340.00% | 88.89% | -172.22% | -44.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.28% | -164.12% | -47.23% | -121.78% | 26.70% |